Gilead Sciences (NASDAQ:GILD) Sets New 52-Week High Following Analyst Upgrade

Gilead Sciences (NASDAQ:GILD) Sets New 52-Week High Following Analyst Upgrade

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday after Leerink Partners raised their price target on the stock from $114.00 to $146.00. Leerink Partners currently has an outperform rating on the stock. Gilead Sciences traded as high as $142.20 and last traded at $141.53, with a volume of 8928 shares trading hands. The stock had previously closed at $141.95. A number of other bro…